GE HealthCare Technologies Inc. GEHC | NASDAQ
After Hours
Next Earnings: Feb 13, 2025
Company Overview:
2.1 Year Performance Metrics:
GEHC Dividend Payments, Yield & Share Price charts
Unlock All Reports & Research Dividend Stocks like a BOSS!
GEHC Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.
Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.
Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.
FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.
Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.
GEHC Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
GEHC Dividends Info:
GEHC Dividend History: Dates, Payments & Yield list
Below is a schedule of all GEHC dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield
| Ex-Date | Payment Date | Amount | TTM Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 01/14/2025 | 02/14/2025 | $0.035 | 0.15% | 0.17% | $84.13 |
| 10/18/2024 | 11/15/2024 | $0.030 | 0.13% | 0.13% | $91.34 |
| 07/19/2024 | 08/15/2024 | $0.030 | 0.15% | 0.15% | $80.44 |
| 04/18/2024 | 05/15/2024 | $0.030 | 0.14% | 0.14% | $84.97 |
| 04/15/2024 | 05/15/2024 | $0.030 | 0.14% | 0.14% | $86.13 |
| 01/12/2024 | 02/15/2024 | $0.030 | 0.16% | 0.16% | $76.17 |
| 10/19/2023 | 11/15/2023 | $0.030 | 0.14% | 0.18% | $65.45 |
| 07/20/2023 | 08/15/2023 | $0.030 | 0.07% | 0.15% | $81.85 |
| 05/22/2023 | 06/15/2023 | $0.030 | 0.04% | 0.15% | $79.08 |
Get the best Dividend Stock Research Tools:
Projected Future Returns & Dividends for GEHC
Based on past 2.1-year performance, here are GEHC growth metrics:Using GEHC CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:
Share price CAGR of +12.09%
Dividend CAGR of +1.55%
| GEHC | |
|---|---|
| Current Price | $87.34 |
| Start Shares | 114.50 |
| Start Value | $10,000 |
| After 10 years: | |
| Final Share Count | 115.55 |
| Dividends Payment | $0.04 |
| Annual Dividends | $16 |
| Yield on cost | 0.16% |
| Share Price | $243.88 |
| Total Dividends | $148 |
| Final Value | $28,180 |
NOTE: Above numbers are our estimate based on GEHC's Dividend and Price CAGR over past 2.1 years.
These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).
We cannot guarantee that your actual returns will meet these estimates.
Company Info
GE HealthCare Technologies Inc. (GEHC) had its IPO on 2022-12-15, and is trader on NASDAQ stock exchange.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
GEHC website: https://www.gehealthcare.com
